Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study

被引:4
|
作者
Uranga, A. [1 ]
Villanueva, A. [2 ]
Lafuente, I [2 ]
Gonzalez, N. [2 ,3 ]
Legarreta, M. J. [2 ]
Aguirre, U. [2 ,3 ]
Espana, P. P. [1 ]
Quintana, J. M. [2 ,3 ]
Garcia-Gutierrez, S. [2 ,3 ]
机构
[1] Hosp Galdakao Usansolo, Serv Resp, Galdakao, Bizkaia, Spain
[2] Hosp Galdakao Usansolo, Unidad Invest, Galdakao, Bizkaia, Spain
[3] Red Invest Serv Sanitarios Enfermedades Cron REDI, Galdakao, Bizkaia, Spain
来源
REVISTA CLINICA ESPANOLA | 2022年 / 222卷 / 01期
关键词
COVID-19; Prognostic factors; Clinical deterioration;
D O I
10.1016/j.rce.2021.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: There is controversy regarding the best predictors of clinical deterioration in COVID-19. Objective: This work aims to identify predictors of risk factors for deterioration in patients hospitalized due to COVID-19. Methods Design: Nested case-control study within a cohort. Setting: 13 acute care centers of the Osakidetza-Basque Health Service. Participants: Patients hospitalized for COVID-19 with clinical deterioration-defined as onset of severe ARDS, ICU admission, or death-were considered cases. Two controls were matched to each case based on age. Sociodemographic data; comorbidities; baseline treatment; symptoms; date of onset; previous consultations; and clinical, analytical, and radiological variables were collected. An explanatory model of clinical deterioration was created by means of conditional logistic regression. Results: A total of 99 cases and 198 controls were included. According to the logistic regression analysis, the independent variables associated with clinical deterioration were: emergency department 0 2 saturation <= 90% (OR 16.6; 95%CI 4-68), pathological chest X-ray (OR 5.6; 95%CI 1.7-18.4), CRP >100 mg/dL (OR 3.62; 95%CI 1.62-8), thrombocytopenia with < 150,000 platelets (OR 4; 95%CI 1.84-8.6); and a medical history of acute myocardial infarction (OR 15.7; 95%CI, 3.29-75.09), COPD (OR 3.05; 95%CI 1.43-6.5), or HT (OR 2.21; 95%CI 1.11-4.4). The model's AUC was 0.86. On the univariate analysis, female sex and presence of dry cough and sore throat were associated with better clinical progress, but were not found to be significant on the multivariate analysis. Conclusion: The variables identified could be useful in clinical practice for the detection of patients at high risk of poor outcomes. (C) 2021 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [41] Predictive factors of hospitalization in an intensive care unit in patients with COVID-19: A case-control study
    Da Silva, Palena Cabral
    Diniz, Alcides da Silva
    De Noronha, Gisele Almeida
    Diniz Araujo, Maria Lucia
    Cabral, Poliana Coelho
    NUTRICION CLINICA Y DIETETICA HOSPITALARIA, 2021, 41 (01): : 123 - 129
  • [42] Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study
    Leulseged, Tigist W.
    Alemahu, Degu G.
    Hassen, Ishmael S.
    Maru, Endalkachew H.
    Zewde, Wuletaw C.
    Chamiso, Negat W.
    Yegele, Kalkidan T.
    Abebe, Daniel S.
    Abdi, Firaol M.
    Minyelshewa, Etsegenet Y.
    Gerbi, Tegenu G.
    Hagos, Helen T.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [43] Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study
    Tigist W. Leulseged
    Degu G. Alemahu
    Ishmael S. Hassen
    Endalkachew H. Maru
    Wuletaw C. Zewde
    Negat W. Chamiso
    Kalkidan T. Yegele
    Daniel S. Abebe
    Firaol M. Abdi
    Etsegenet Y. Minyelshewa
    Tegenu G. Gerbi
    Helen T. Hagos
    BMC Infectious Diseases, 21
  • [44] Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study
    Gastelum-Strozzi, Alfonso
    Pascual, Virginia
    Hernandez-Garduno, Adolfo
    Moctezuma-Rios, Jose Francisco
    Guaracha-Basanez, Guillermo Arturo
    Sotelo, Thalya
    Garcia-Garcia, Conrado
    Contreras-Yanez, Irazu
    Alvarez-Hernandez, Everardo
    Infante-Castaneda, Claudia
    Pelaez-Ballestas, Ingris
    CLINICAL RHEUMATOLOGY, 2022, 41 (10) : 3211 - 3218
  • [45] Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study
    Zhou, Shaodan
    Wen, Yishuang
    Liu, Chao
    Zhong, Jian
    Liang, Manli
    Wu, Yu
    Lv, Sirao
    Gong, Zhuowei
    Lao, Dayuan
    Li, Taiyan
    Lu, Ting
    Tang, Jingqun
    Mo, Xuean
    Huang, Wen
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 3157 - 3168
  • [46] Changes of lymphocyte subsets in patients with COVID-19 and clinical significance: a case-control observational study
    Yang Guang
    Feng Fan
    Li Xue
    Zhang Tian
    Li Xiang
    Li Boan
    生物组学研究杂志(英文), 2021, 04 (01) : 36 - 39
  • [47] RISK FACTORS ASSOCIATED WITH SEPSIS IN CANCER PATIENTS ADMITTED TO THE ICU: A CASE-CONTROL STUDY
    Quinde Villacrs, Camila
    Sebastian Ochoa, G.
    Schettino, Marissa
    Benitez, Elizabeth
    Sanchez Hilbron, Alberto
    Cuenca, John
    CRITICAL CARE MEDICINE, 2020, 48
  • [48] Intravenous Immunoglobulin for Treatment of Patients with COVID-19: A Case-control Study
    Khodashahi, Rozita
    Naderi, Hamid Reza
    Sedaghat, Alireza
    Allahyari, Abolghasem
    Sarjamee, Soroush
    Eshaghi, Soudabe
    Fazeli, Farzaneh
    Hoseini, Benyamin
    Dadgarmoghaddam, Maliheh
    Khodashahi, Mandana
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2021, 16 (01):
  • [49] Dermatologic comorbidities of the patients with severe COVID-19: A case-control study
    Kutlu, Omer
    ogut, Neslihan Demirel
    Erbagci, Ece
    Metin, Ahmet
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [50] COVID-19 hospitalized patients and oral changes: a case-control study
    Ferreira, Marceli Dias
    Lopez, Lourdes Zeballos
    da Silva, Fernanda Pereira
    Mileo, Fernanda Couto
    Bortoluzzi, Marcelo Carlos
    dos Santos, Fabio Andre
    CLINICAL ORAL INVESTIGATIONS, 2023, 27 (08) : 4481 - 4491